A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination

J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1369-e1371. doi: 10.1111/jdv.19414. Epub 2023 Aug 19.

Authors

L Ligrone¹, S Lembo², F Cillo³, S Spennato³, G Fabbrocini³, A Raimondo²

Affiliations

¹ Dermatologic Unit, Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy.
² Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana' University of Salerno, Salerno, Italy.
³ Dermatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.

PMID: 37561928
DOI: 10.1111/jdv.19414

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Pemphigus* / drug therapy
Recurrence
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines